Dr. Brandon D. Pomeroy, MD
Urology (Urology Physician)
- Medicare participating
At a glance
- Years since graduation
- 34
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 638
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
MO license 2001023021 · KS license 04-27485
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- St Lukes Hospital of Kansas City Kansas City, MO
- Saint Luke's South Hospital Overland PArk, KS
- Golden Valley Memorial Hospital Clinton, MO
- Hedrick Medical Center Chillicothe, MO
- Allen County Regional Hospital Iola, KS
Medical groups
- Kansas City Urology Care PA (71 clinicians)
- Saint Lukes Hospital of Chillicothe (25 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 638
- Services billed
- 4,013
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 685 | 482 |
| Urinalysis, manual test | 509 | 373 |
| Ultrasound measurement of bladder capacity after voiding | 293 | 223 |
| Insertion of needle into vein for collection of blood sample | 193 | 160 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 174 | 23 |
| Psa (prostate specific antigen) measurement, total | 154 | 138 |
| Diagnostic exam of bladder and urethra using an endoscope | 98 | 64 |
| New patient office or other outpatient visit, 45-59 minutes | 90 | 90 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 39 | 24 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 21 | 21 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Kansas City, MO | 915 |
| Finasteride Other prescribers in Kansas City, MO | 364 |
| Solifenacin Succinate Other prescribers in Kansas City, MO | 175 |
| Myrbetriq (mirabegron) Other prescribers in Kansas City, MO | 138 |
| Trospium Chloride Other prescribers in Kansas City, MO | 86 |
| Nitrofurantoin Mono-Macro (nitrofurantoin monohyd/m-cryst) Other prescribers in Kansas City, MO | 67 |
| Alfuzosin Hcl Er (alfuzosin hcl) Other prescribers in Kansas City, MO | 47 |
| Tolterodine Tartrate Other prescribers in Kansas City, MO | 41 |
| Potassium Citrate Er (potassium citrate) Other prescribers in Kansas City, MO | 37 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Kansas City, MO | 35 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 8 payments worth $308 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $134 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $35.06 |
| Progenics Pharmaceuticals, Inc. | $28.82 |
| Novo Nordisk Inc | $28.40 |
| Urogen Pharma, Inc. | $27.07 |
| Ferring Pharmaceuticals Inc. | $22.65 |
| Olympus America Inc. | $17.25 |
| Laborie Medical Technologies Corp. | $14.35 |
| Food and Beverage | $273 |
|---|---|
| Education | $35.06 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Nov 19, 2025 | Education IMFINZI · Oncology · in-kind Company’s descriptionJournal Article | $35.06 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.